KMC Speciality Hospitals (India) Limited (BOM:524520)
India · Delayed Price · Currency is INR 87.35
+0.11 (0.13%)
At close: Feb 12, 2026
BOM:524520 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 2,844 | 2,316 | 1,772 | 1,558 | 1,361 | 1,026 |
| 2,844 | 2,316 | 1,772 | 1,558 | 1,361 | 1,026 | |
Revenue Growth (YoY) | 31.96% | 30.72% | 13.75% | 14.46% | 32.58% | 6.71% |
Cost of Revenue | 1,146 | 952.29 | 688.08 | 585.69 | 524.46 | 415.09 |
Gross Profit | 1,698 | 1,364 | 1,084 | 971.87 | 836.27 | 611.28 |
Selling, General & Admin | 74.64 | 74.64 | 35.27 | 35.42 | 29.13 | 18.01 |
Other Operating Expenses | 845.71 | 716.76 | 566.32 | 517.64 | 432.11 | 353.4 |
Operating Expenses | 1,130 | 982.24 | 699.96 | 632.92 | 528.5 | 439.27 |
Operating Income | 568.82 | 381.45 | 383.71 | 338.95 | 307.77 | 172.01 |
Interest Expense | -85.89 | -94.16 | -11.64 | -8.11 | -6.96 | -9.52 |
Interest & Investment Income | 8.51 | 8.51 | 20.33 | 17.67 | 12.45 | 8.92 |
Other Non Operating Income (Expenses) | 28.88 | 20.12 | 13.38 | 12.32 | 7.43 | 8.85 |
EBT Excluding Unusual Items | 520.33 | 315.92 | 405.78 | 360.83 | 320.69 | 180.25 |
Gain (Loss) on Sale of Assets | 0.11 | 0.11 | -0.2 | -0.93 | 0.29 | 0.19 |
Pretax Income | 520.44 | 316.03 | 405.58 | 359.9 | 320.98 | 180.44 |
Income Tax Expense | 154.18 | 101.76 | 101.79 | 93.02 | 83.72 | 52.64 |
Net Income | 366.26 | 214.27 | 303.79 | 266.88 | 237.26 | 127.79 |
Net Income to Common | 366.26 | 214.27 | 303.79 | 266.88 | 237.26 | 127.79 |
Net Income Growth | 52.66% | -29.47% | 13.83% | 12.49% | 85.66% | 8.83% |
Shares Outstanding (Basic) | 163 | 163 | 163 | 163 | 163 | 163 |
Shares Outstanding (Diluted) | 163 | 163 | 163 | 163 | 163 | 163 |
EPS (Basic) | 2.24 | 1.31 | 1.86 | 1.64 | 1.45 | 0.78 |
EPS (Diluted) | 2.24 | 1.31 | 1.86 | 1.64 | 1.45 | 0.78 |
EPS Growth | 52.16% | -29.57% | 13.66% | 12.49% | 85.66% | 8.83% |
Free Cash Flow | - | -62.99 | -368.51 | -117.89 | 156.4 | -152.52 |
Free Cash Flow Per Share | - | -0.39 | -2.26 | -0.72 | 0.96 | -0.94 |
Gross Margin | 59.71% | 58.88% | 61.16% | 62.40% | 61.46% | 59.56% |
Operating Margin | 20.00% | 16.47% | 21.66% | 21.76% | 22.62% | 16.76% |
Profit Margin | 12.88% | 9.25% | 17.15% | 17.14% | 17.44% | 12.45% |
Free Cash Flow Margin | - | -2.72% | -20.80% | -7.57% | 11.49% | -14.86% |
EBITDA | 805.32 | 549.87 | 461.36 | 405.62 | 364 | 226.24 |
EBITDA Margin | 28.31% | 23.74% | 26.04% | 26.04% | 26.75% | 22.04% |
D&A For EBITDA | 236.5 | 168.42 | 77.65 | 66.67 | 56.24 | 54.24 |
EBIT | 568.82 | 381.45 | 383.71 | 338.95 | 307.77 | 172.01 |
EBIT Margin | 20.00% | 16.47% | 21.66% | 21.76% | 22.62% | 16.76% |
Effective Tax Rate | 29.63% | 32.20% | 25.10% | 25.85% | 26.08% | 29.18% |
Revenue as Reported | 2,884 | 2,347 | 1,807 | 1,589 | 1,382 | 1,046 |
Advertising Expenses | - | 57.84 | 28.85 | 27.4 | 22.35 | 12.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.